Full Text (PDF)
Letter to Editor

Ibrutinib In Hematology

Iffat Jamal

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Indian Journal of Pathology: Research and Practice 13(4):p 117-117, Oct. Dec. 2024. | DOI: https://doi.org/10.21088/IJPRP_17056_2024.5

How Cite This Article:


Timeline

Received : October 15, 2024         Accepted : November 14, 2024          Published : December 30, 2024

Abstract

NA


References

No records found.


Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

No conflicts of interest in this work.


About this article


Cite this article


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
October 15, 2024 November 14, 2024 December 30, 2024

DOI: https://doi.org/10.21088/IJPRP_17056_2024.5

Keywords


Article Level Metrics

Last Updated

Sunday 12 July 2026, 13:44:53 (IST)


2018

Accesses

5
434
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received October 15, 2024
Accepted November 14, 2024
Published December 30, 2024

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share